{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260504237451/en/Enanta-Pharmaceuticals-to-Present-Data-for-its-Respiratory-Syncytial-Virus-and-STAT6-Inhibitor-Programs-at-the-American-Thoracic-Society-International-Conference-2026", "message": "News view counter 699444 successfully enlarged"}